6-115944425-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002031.3(FRK):āc.959A>Gā(p.Asn320Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000245 in 1,592,646 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_002031.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRK | NM_002031.3 | c.959A>G | p.Asn320Ser | missense_variant, splice_region_variant | 6/8 | ENST00000606080.2 | NP_002022.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRK | ENST00000606080.2 | c.959A>G | p.Asn320Ser | missense_variant, splice_region_variant | 6/8 | 1 | NM_002031.3 | ENSP00000476145.1 | ||
ENSG00000289376 | ENST00000692859.2 | n.223-42247A>G | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000303 AC: 7AN: 231368Hom.: 0 AF XY: 0.0000160 AC XY: 2AN XY: 125150
GnomAD4 exome AF: 0.0000125 AC: 18AN: 1440508Hom.: 0 Cov.: 30 AF XY: 0.00000698 AC XY: 5AN XY: 716044
GnomAD4 genome AF: 0.000138 AC: 21AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74324
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at